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Abstract
Adrenal myelolipoma is a rare benign neoplasm composed of mature adipose and hematopoietic
tissue. Most lesions are small, unilateral and asymptomatic, discovered incidentally at autopsy or on
imaging studies performed for other reasons. We would like to present a case report of this rare
tumour. Cross-sectional imaging is helpful in making a pre-operative diagnosis. The size of the lesion
should be a criterion for surgical intervention.
Case presentation
A 72-year-old Caucasian lady presented to her general
practitioner with a two-week history of dysuria. She had
no fever, abdominal pain, or gastro-intestinal symptoms.
On clinical examination, no abnormalities were detected.
The urine culture grew Escheria Coli, and the patient was
given appropriate antibiotics. In the past, she had had a
moderately dysplastic tubullovillous adenoma of the
colon, which completely resected. Apart from this she
had no past history. She was not on any regular
medication and was of sober habits. An ultrasound scan
(US) of the abdomen and pelvis showed a mixed
echogenic mass measuring 13 cm above the right kidney
and posterior to the liver. The mass was well-defined and
showed central necrotic changes (Figure 1).
The computed tomography scan (CT) revealed a lesion of
12 cm diameter, sharply outlined, consisting of mostly
fatty tissue, originating from the right kidney or the right
adrenal gland (Figure 2). To ascertain the origin of the
lesion, magnetic resonance imaging (MRI) of the abdo-
men was arranged.
The MRI scan showed the mass to be an adrenal
myelolipoma, which measured 11.0 cm in diameter. The
mass returned a high signal on both T1 and T2 weighted
images. There appeared to be some necrotic areas within
the lesion. On the T1 fat suppressed images, it lost signal
completely, confirming its fatty nature. There were no
focal areas of enhancement within the mass following
administration of contrast (Figure 3). On both CT and
MRI, there were no liver lesions. Laboratory tests, which
included full blood count, urea and electrolytes, and liver
function tests, were within normal range. The 24-hour
urinary excretions of cortisol, noradrenalin, adrenaline
and dopamine were normal.
A repeat MRI scan showed that the mass had increased in
size to 12.0 × 10.9 cm, and had become more hetero-
geneous. Her case was discussed in our endocrine
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and change in appearance, malignancy could not be
excluded. She underwent an open right adrenalectomy.
The surgically removed specimen weighed 573 grams and
had a maximum dimension of 14.5 cm (Figure 4). The
histology of the specimen confirmed it to be adrenal
myelolipoma. There was no evidence of malignancy.
Discussion
The clinical significance of these adrenal neoplasms is
twofold. First, they have been detected as incidental
findings with increasing frequency in recent years, due to
the increasing use of CT scans and magnetic resonance
imaging. Second, on very rare occasions adrenal myeloli-
pomas are functional- till 2004 there were only 25 cases of
endocrine dysfunction associated with myelolipoma
reported in the English and Japanese literature [1]. Surgical
treatment becomes necessary when the tumours are
functional or increase in size or become symptomatic [2].
Figure 1. US picture of a 13 cm mixed echogenic mass
seen above the right kidney and posterior to the liver.
Figure 2. CT showing a 12 cm mass, sharply outlined,
consisting of mostly fatty tissue, originating from the right
kidney or the right adrenal gland.
Figure 3. MRI confirming that the mass is an adrenal
myelolipoma.
Figure 4. Histological picture showing mature fatty and
myeloid elements.
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from 0.08% to 0.4 % .The male to female ratio is 1:1, and
are commonly found in the fifth to seventh decade. Most
myelolipomas are asymptomatic and have no endocrine
function. They are usually discovered incidentally on
autopsy, surgery, or as an incidentalomas on imaging for
other reasons [1]. They are found to constitute 15% of
adrenal incidentalomas because of frequent use of non-
invasive imaging techniques [3]. Occasionally, patients
present with abdominal pain secondary to haemorrhage
(more likely when it is predominantly composed of
myeloid tissue), tumour necrosis, or mechanical compres-
sion from tumour bulk. After a search of the UK Medline
database, no figures were outlined to determine the
percentagerateofeachcomplication.Otherrarepresenting
symptoms include haematuria and abdominal mass [4].
Four distinct clinico-pathological patterns have been
described - isolated adrenal myelolipoma, adrenal myelo-
lipoma with haemorrhage, extra adrenal myelolipoma,
and myelolipoma associated with other adrenal diseases
such as non-functioning adrenal adenomas or endocrine
disorders. Adrenal myelolipoma in association with
Cushing’s syndrome, Conn’s syndrome, and congenital
adrenal hyperplasia due to 21 alpha-hydroxylase or 17
alpha-hydroxylase deficiencies have been reported [5].
Tumour size has been reported in literature from a few
millimetres to more than 30 cm, but rarely exceeds 5 cm .
They are mostly unilateral and do not undergo malignant
transformation [6]. Bilateral tumours occur in about
10% of cases [7].
The appearance of myelolipoma on imaging is based on
the fat content of the lesion. They thus appear echogenic
on ultrasound, and as low attenuation lesions on CT scan.
Ultrasound of the abdomen is able to differentiate the
supra-renal mass from the kidneys, but it cannot confirm a
myelolipoma. On CT scan, adrenal myelolipoma is seen as
a hypodense, non enhancing lesion with attenuation
values suggestive of fat [8]. MRI of adrenal myelolipoma
characteristically demonstrates a bright signal on T1-
weighted and T2-weighted sequences, consistent with the
presence of fat. The lesion enhances brightly after
intravenous administration of gadolinium. Decrease in
signal with fat suppression or phase cancellation is
confirmatory of adrenal myelolipoma.
The differential diagnosis includes retroperitoneal lipo-
sarcoma, adrenal adenoma, adrenal lymphoma, and
metastases. Most myelolipomas present in the adrenal
gland, and are well circumscribed. The majority of fat-
containing tumours are well differentiated liposarcoma,
appearing almost morphologically identical to adrenal
myelolipoma [9].
The asymptomatic small lesions of less than 4 cm should
be followed up with CT scan or MRI; though some
advocate just a clinical follow-up without routine follow-
up with radiological investigations [5]. Surgery is indicated
in patients who are symptomatic, or lesion of more than
4 cm in size due to rare chances of rupture [10], or if
malignancy is suspected. Transcatheter embolization prior
to surgical resection has been used successfully to achieve
haemostasis in cases of ruptured myelolipomas leading to
retroperitoneal haemorrhage [1]. In case of bilateral
myelolipoma a staged tumour removal is preferable,
removing the larger one and continuing to observe the
contralateral myelolipoma as long as possible in an effort
to avoid adrenal insufficiency and a lifetime of steroid
replacement. If CT shows non-homogenous characteristics
or if the diagnosis is in doubt, an image guided needle
biopsy could be performed to confirm the diagnosis but
this approach bears the risk of rupture and bleeding [4].
The aetiology of myelolipoma is unknown. One theory by
D. C. Collins suggests that a myelolipoma represents a site
of extramedullary haematopoiesis [11]. The most widely
accepted theory, as cited by Meaglia and Schmidt in a 1992
study of the natural history of adrenal myelolipoma, is the
existence of metaplasia of the reticuloendothelial cells of
blood capillaries in the adrenal gland in response to
stimuli such as necrosis, infection, stress or long-term
ACTH stimulation [4].
Conclusion
Adrenal myelolipoma is a relatively rare tumour. Cross-
sectional imaging is helpful in making a pre-operative
diagnosis. In order to prevent serious morbidity or exclude
malignancy, criteria for surgical intervention should
include size of more than 4 cm at presentation or increase
in size or change in appearance.
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